Keizo Koya

Keizo Koya appears in our data through filings on Madrigal Pharmaceuticals, Inc. shares, published by SEC (Form 4). The record holds 7 filings, for trades running from 24 August 2009 to 1 March 2012.

Both buying and selling appear: 1 purchase worth €20k, against 4 sales worth €173k. Sales outweigh purchases by €153k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 2 share grants. In 2012 alone, the filings show no purchases and 1 sale.

The newest entry dates from 5 March 2012: an open-market sale of €24k, in Madrigal Pharmaceuticals, Inc. The most recent open-market purchase was published on 26 August 2009, 6,284 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.